Gestational Hypertension Clinical Trial
Official title:
Use of Angiogenic Factors in the Conservative Management of Gestational Hypertension. Prospective, Randomised, Controlled Study.
Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit. One of the most controversial scenarios is gestational hypertension, a group of hypertensive disorders considered the mildest form of the pre-eclamptic spectrum, where current recommendations indicate termination of pregnancy at 37 weeks. However, the decision is based on outdated guidelines developed at a time when angiogenic factors were just beginning to be known. The purpose of the study is to use angiogenic factors as a guide to decide the most appropriate gestational age for termination of pregnancy in patients diagnosed with gestational hypertension.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02384226 -
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
|
||
Completed |
NCT02148965 -
Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial
|
N/A | |
Completed |
NCT03215173 -
Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease
|
N/A | |
Completed |
NCT03323762 -
Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia
|
N/A | |
Recruiting |
NCT04604535 -
The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy
|
N/A | |
Recruiting |
NCT02920593 -
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
|
Phase 4 | |
Recruiting |
NCT04877119 -
sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study
|
||
Recruiting |
NCT05773677 -
Diet in Twin Pregnancy: the Wellness of Mother and Babies.
|
N/A | |
Completed |
NCT04119232 -
Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
|
N/A | |
Completed |
NCT05595629 -
App-based Remote Blood Pressure Monitoring
|
N/A | |
Completed |
NCT05542654 -
The Effect of Foot Massage on Blood Pressure and Anxiety Levels in Pregnants With Hypertension
|
N/A | |
Recruiting |
NCT03298802 -
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
|
Phase 3 | |
Completed |
NCT03922087 -
No-worry Baby Project
|
||
Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
Recruiting |
NCT05888467 -
Physical Activity and Cardiovascular Profile of Pre-conceptional Women at Risk for GHD
|
N/A | |
Not yet recruiting |
NCT03930693 -
Role of the Oral Microbiome in Blood Pressure Regulation in Pregnancy
|
Early Phase 1 | |
Not yet recruiting |
NCT06320054 -
Preventing Obstetric Complications With Dietary Intervention
|
N/A | |
Completed |
NCT05124327 -
Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy
|
N/A | |
Completed |
NCT05517512 -
Relation Between Protein 13 and Gestational Hypertensive Disorder
|
||
Recruiting |
NCT05752955 -
SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth
|
N/A |